BP plc BP, the British oil and gas giant, has recently secured a win in an arbitration proceeding against Venture Global Inc. VG over the latter’s failure to supply liquefied natural gas (LNG) ...

BP’s stock narrative has shifted as analysts adjust their price targets in response to evolving market and company developments. A small uptick in BP’s fair value, along with a decline in discount ...

HOUSTON (Reuters) -BP has won its arbitration case against Venture Global over the U.S. supplier's failure to deliver liquefied natural gas under a long-term contract that was due to start in late ...

BP approved the Tiber-Guadalupe oil project in the Gulf of America, which involves installing a new production platform with a capacity of 80,000 bpd. BP PLC has announced a positive FID (final ...

Not only are some of the world's top oil-and-gas companies pulling away from renewables and embracing fossil fuels even more, but they're also doubling down by making major plays in the crude-rich ...

The company now sees global oil demand peaking in the mid-2030s instead of before 2030. BP: declines are coming only gradually, driven by efficiency gains and EV adoption but offset by petrochemicals.

BP Plc (NYSE: BP) approved a $5 billion oil and gas project in the Gulf of America, reinforcing its commitment to the offshore basin as a driver of future growth. The Tiber-Guadalupe development is ...

BP has sanctioned its wholly-owned $5 billion Tiber-Guadalupe deep-water project, marking the second time in the past two years that it has reached a final investment decision for a major US Gulf ...

BP has cancelled plans for a major biofuels facility at its Rotterdam refinery, scoring another setback for Europe’s drive to scale advanced biofuels, as reported by Reuters. The energy giant ...

BP has signed a preliminary agreement with the Egyptian Natural Gas Holding Company (EGAS) to drill five new deepwater gas wells in the Mediterranean Sea, Egypt’s Petroleum Ministry said on Monday.

MADRID, Spain—Baxdrostat (AstraZeneca), an investigational aldosterone synthase inhibitor, provides substantial reductions in blood pressure when added to background therapy in patients with ...